News Focus
News Focus
icon url

justrpaul

01/26/15 12:33 PM

#186593 RE: DewDiligence #186590

Unless ESRX is doing outreach to HCV patients, the 92/8 split is surely a reasonable first approximation of patients in treatment non-ESRX/ESRX.